These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8415867)

  • 1. G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in rats.
    Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Oriti S; Spignoli G; Caputi AP
    Pharmacology; 1993 Sep; 47(3):167-75. PubMed ID: 8415867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injury.
    Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Oriti S; Faggiotto A; Caputi AP
    Agents Actions; 1993 Jul; 39(3-4):143-9. PubMed ID: 8304242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556.
    Altavilla D; Squadrito F; Campo GM; Saitta A; Squadrito G; Quartarone C; Deodato B; Arlotta M; Ferlito M; Minutoli L; Tringali M; Urna G; Sardella A; Caputi AP
    Life Sci; 2000 Oct; 67(21):2615-29. PubMed ID: 11104363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
    Smith EF; Griswold DE; Egan JW; Hillegass LM; DiMartino MJ
    J Cardiovasc Pharmacol; 1989 May; 13(5):715-22. PubMed ID: 2472519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin-A reduces leukocyte accumulation and protects against myocardial ischaemia reperfusion injury in rats.
    Squadrito F; Altavilla D; Squadrito G; Saitta A; Campo GM; Arlotta M; Quartarone C; Ferlito M; Caputi AP
    Eur J Pharmacol; 1999 Jan; 364(2-3):159-68. PubMed ID: 9932719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury.
    Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Calapai G; Bussolino F; Caputi AP
    J Lipid Mediat; 1993 Aug; 8(1):53-65. PubMed ID: 8257777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia- reperfusion injury.
    Squadrito F; Altavilla D; Squadrito G; Saitta A; Deodato B; Arlotta M; Minutoli L; Quartarone C; Ferlito M; Caputi AP
    J Mol Cell Cardiol; 2000 Mar; 32(3):429-40. PubMed ID: 10731442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of L-659,989, a platelet-activating factor receptor antagonist, in myocardial ischemia and reperfusion in rats.
    Ioculano M; Squadrito F; Altavilla D; Canale P; Campo GM; Bussolino F; Sardella A; Urna G; Caputi AP
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):7-12. PubMed ID: 7511738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cloricromene, a coumarine derivative, on leukocyte accumulation, myocardial necrosis and TNF-alpha production in myocardial ischaemia-reperfusion injury.
    Squadrito F; Altavilla D; Zingarelli B; Ioculano M; Calapai G; Campo GM; Miceli A; Prosdocimi M; Caputi AP
    Life Sci; 1993; 53(4):341-55. PubMed ID: 8392130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-selectin in the pathogenesis of experimental myocardial ischemia-reperfusion injury.
    Altavilla D; Squadrito F; Ioculano M; Canale P; Campo GM; Zingarelli B; Caputi AP
    Eur J Pharmacol; 1994 Jan; 270(1):45-51. PubMed ID: 7512508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17Beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat.
    Squadrito F; Altavilla D; Squadrito G; Campo GM; Arlotta M; Arcoraci V; Minutoli L; Serrano M; Saitta A; Caputi AP
    Eur J Pharmacol; 1997 Sep; 335(2-3):185-92. PubMed ID: 9369372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor necrosis factor in myocardial ischemia and reperfusion].
    Squadrito F; Saitta A; Altavilla D; Campo GM; Ioculano M; Squadrito G; Caputi AP
    Cardiologia; 1993 Jan; 38(1):45-51. PubMed ID: 8388776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in myocardial ischemic/reperfusion injury and neutrophil accumulation after therapeutic administration of streptokinase.
    Smith EF; Nichols AJ; Sellers TS; O'Brien SR; Griswold DE; Egan JW; Hillegass LM; Vasko JA; Slivjak MJ; Davis PA
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):729-38. PubMed ID: 1723770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist.
    Nichols WW; Mehta J; Wargovich TJ; Franzini D; Lawson D
    Angiology; 1989 Mar; 40(3):209-21. PubMed ID: 2537051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against intercellular adhesion molecule 1 protect against myocardial ischaemia-reperfusion injury in rat.
    Ioculano M; Squadrito F; Altavilla D; Canale P; Squadrito G; Campo GM; Saitta A; Caputi AP
    Eur J Pharmacol; 1994 Oct; 264(2):143-9. PubMed ID: 7851476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesis.
    Altavilla D; Squadrito F; Canale P; Ioculano M; Squadrito G; Campo GM; Serranò M; Sardella A; Urna G; Spignoli G
    Eur J Pharmacol; 1995 Nov; 286(1):31-9. PubMed ID: 8566149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of IRFI-016, a new antioxidant agent, in myocardial damage, following coronary artery occlusion and reperfusion in the rat.
    Campo GM; Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Pollicino AM; Rizzo A; Calapai G; Calandra S; Scuri R
    Pharmacology; 1994 Mar; 48(3):157-66. PubMed ID: 8153143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
    Canale P; Squadrito F; Altavilla D; Ioculano M; Campo GM; Squadrito G; Urna G; Sardella A; Caputi AP
    Pharmacology; 1994 Dec; 49(6):376-85. PubMed ID: 7878075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective antagonism of peptidoleukotriene responses does not reduce myocardial damage or neutrophil accumulation following coronary artery occlusion with reperfusion.
    Egan JW; Griswold DE; Hillegass LM; Newton JF; Eckardt RD; Slivjak MJ; Smith EF
    Prostaglandins; 1989 May; 37(5):597-613. PubMed ID: 2544926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury.
    Deodato B; Altavilla D; Squadrito G; Campo GM; Arlotta M; Minutoli L; Saitta A; Cucinotta D; Calapai G; Caputi AP; Miano M; Squadrito F
    Br J Pharmacol; 1999 Dec; 128(8):1683-90. PubMed ID: 10588923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.